Cangrelor Tetrasodium

CHEMBL1097279 Phase 4 Approved Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

864.3 g/mol

LogP

—

Phase

4

The tetrasodium salt form of cangrelor, formulated for intravenous infusion to provide rapid platelet inhibition during coronary stenting procedures. Like cangrelor, its reversible binding and short duration allow precise control of antiplatelet therapy in procedural settings. It reduces the risk of periprocedural heart attack and stent thrombosis.

Molecular Weight

864.3000 g/mol

TPSA

318.00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure

Embed this structure

SMILES

CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])C(Cl)(Cl)P(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+]

InChI

InChI=1S/C17H25Cl2F3N5O12P3S2.4Na/c1-43-5-3-23-12-9-13(26-15(25-12)44-4-2-16(20,21)22)27(7-24-9)14-11(29)10(28)8(38-14)6-37-42(35,36)39-41(33,34)17(18,19)40(30,31)32;;;;/h7-8,10-11,14,28-29H,2-6H2,1H3,(H,33,34)(H,35,36)(H,23,25,26)(H2,30,31,32);;;;/q;4*+1/p-4/t8-,10-,11-,14-;;;;/m1..../s1

Molecular Formula

C17H21Cl2F3N5Na4O12P3S2

HBD / HBA

3 / 21

Rotatable Bonds

14

Heavy Atoms

48

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

The tetrasodium salt form of cangrelor, formulated for intravenous infusion to provide rapid platelet inhibition during coronary stenting procedures. Like cangrelor, its reversible binding and short duration allow precise control of antiplatelet therapy in procedural settings. It reduces the risk of periprocedural heart attack and stent thrombosis.

Yes, Cangrelor Tetrasodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1097279. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 10260031. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Looking for patient-friendly information?

Cangrelor Tetrasodium on PillFYI

Structure

Quick Data

Formula: C17H21Cl2F3N5Na4O12P3S2

External Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.